Home › Funds › D. E. Shaw & Co › VRTX
D. E. Shaw & Co position in VRTX
VERTEX PHARMACEUTICALS INCORPORATED · Health Care
Latest position (Q2 2026)18.20K sh
Reported value held$9.04M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.81M | $329.01M | New |
| Q4 2021 | 1.07M | $235.46M | Reduce |
| Q1 2022 | 764.65K | $199.55M | Reduce |
| Q2 2022 | 296.74K | $83.62M | Reduce |
| Q3 2022 | 126.25K | $36.55M | Reduce |
| Q4 2022 | 118.53K | $34.23M | Reduce |
| Q1 2023 | 204.93K | $64.57M | Add |
| Q2 2023 | 251.76K | $88.60M | Add |
| Q3 2023 | 258.39K | $89.85M | Add |
| Q4 2023 | 212.98K | $86.66M | Reduce |
| Q1 2024 | 364.36K | $152.31M | Add |
| Q2 2024 | 175.06K | $82.06M | Reduce |
| Q3 2024 | 152.51K | $70.93M | Reduce |
| Q4 2024 | 265.68K | $106.99M | Add |
| Q1 2025 | 86.93K | $42.15M | Reduce |
| Q2 2025 | 28.68K | $12.77M | Reduce |
| Q3 2025 | 51.34K | $20.11M | Add |
| Q4 2025 | 42.50K | $19.27M | Reduce |
| Q1 2026 | 248.96K | $111.17M | Add |
| Q2 2026 | 18.20K | $9.04M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- BlackRock Inc 24.11M sh · $11.98B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Geode Capital Management 6.02M sh · $2.98B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Goldman Sachs Group 2.53M sh · $1.26B · Q2 2026